Search

This initiative aims to have a positive long term impact on the environment, economy and society by helping achieve 10 of the Sustainable Development Goals (SDG).

January 10th, in an event with numerous institutional representatives, headed by the Lehendakari Iñigo Urkullu, together with representatives from the business, financial, scientific-technological and

The Investor Day, organized by AseBio and positioned as the benchmark meeting between investors and Spanish biotech companies, will take place on May 15th.

Innovation has enabled breakthroughs such as recent drugs for Alzheimer's disease, the use of devices that stimulate brain function for the treatment of certain pathologies or Virtual Reality for post

Funding will Support Development of AI Clinician, Using Spatial Computing.

AseBio has been a key player in the journey taken over these 25 years by biotechnology in Spain, positioning itself as a strategic agent in the face of challenges and future prospects.

The objective of this study was to analyze the impact of glaucoma in ambulatory centers and hospitals in Spain over the past decade and to measure the associated direct medical costs and incidence.

Due to Spain's scientific and technological potential, both in the public and private sectors, our country has the responsibility to give a new boost to the biotechnological sector and thus respond to